During the past decade, Mater Children's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mater Children's Hospital" #1 sponsor was "John Hunter Children's Hospital" with 1 trials, followed by "Melbourne Health" with 1 trials sponsored, "Phoenix Children's Hospital" with 1 trials sponsored, "ResMed" with 1 trials sponsored and "The University of Queensland" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mater Children's Hospital" #1 collaborator was "Lady Cilento Children's Hospital, Brisbane" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "NovoNordisk Pharmaceuticals" with 1 trials as a collaborator, "Royal Children's Hospital" with 1 trials as a collaborator and "Royal North Shore Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mater Children's Hospital" are "Type 1 Diabetes" (2 trials), "Bronchiectasis" (1 trials), "Cystic Fibrosis" (1 trials), "Obstructive Sleep Apnea" (1 trials) and "Respiratory Insufficiency" (1 trials). Many other conditions were trialed in "Mater Children's Hospital" in a lesser frequency.

Most popular intervention types in "Mater Children's Hospital" are "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azithromycin" (1 trials), "Fixed dose" (1 trials), "Intranasal insulin" (1 trials), "Placebo" (1 trials) and "Placebo control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater Children's Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mater Children's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mater Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mater Children's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".